Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 391 AL 405

PUBMED

Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.

Dougherty SE, Reeves JL, Lucas EK, Gamble KL, Lesort M, Cowell RM.

Exp Neurol. 2012 Jul;236(1):171-8. doi: 10.1016/j.expneurol.2012.04.015.

0

0

0

PUBMED

SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo.

Bobrowska A, Donmez G, Weiss A, Guarente L, Bates G.

PLoS One. 2012;7(4):e34805. doi: 10.1371/journal.pone.0034805.

0

0

0

PUBMED

Striatal microinjection of Sydenham chorea antibodies: using a rat model to examine the dopamine hypothesis.

Ben-Pazi H, Sadan O, Offen D.

J Mol Neurosci. 2012 Jan;46(1):162-6. doi: 10.1007/s12031-011-9559-6.

0

0

0

PUBMED

Acute chorea and type 1 diabetes mellitus: clinical and neuroimaging findings.

Alves C, Sampaio S, Barbosa V, Machado M.

Pediatr Diabetes. 2012 Sep;13(6):e30-4. doi: 10.1111/j.1399-5448.2012.00856.x. Review.

0

0

0

PUBMED

Hypothalamic and Limbic System Changes in Huntington's Disease.

Petersén A, Gabery S.

J Huntingtons Dis. 2012;1(1):5-16. doi: 10.3233/JHD-2012-120006. Review.

0

0

0

PUBMED

Age, CAG repeat length, and clinical progression in Huntington's disease.

Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA.

Mov Disord. 2012 Feb;27(2):272-6. doi: 10.1002/mds.24024.

0

0

0

PUBMED

Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.

Moreno JL, Palau Fayos JM, Díaz de Santiago A, García de Yébenes J.

J Huntingtons Dis. 2012;1(1):31-2. doi: 10.3233/JHD-2012-120008. No abstract available.

0

0

0

PUBMED

Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay.

Gupta S, Jie S, Colby DW.

J Biol Chem. 2012 Mar 23;287(13):9982-9. doi: 10.1074/jbc.M111.305417.

0

0

0

PUBMED

Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.

Dumas EM, Say MJ, Jones R, Labuschagne I, O'Regan AM, Hart EP, van den Bogaard SJ, Queller S, Justo D, Coleman A, Dar Santos RC, Dürr A, Leavitt BR, Tabrizi SJ, Roos RA, Stout JC.

J Huntingtons Dis. 2012;1(1):97-106. doi: 10.3233/JHD-2012-120010.

0

0

0

PUBMED

Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.

Chiodi V, Uchigashima M, Beggiato S, Ferrante A, Armida M, Martire A, Potenza RL, Ferraro L, Tanganelli S, Watanabe M, Domenici MR, Popoli P.

Neurobiol Dis. 2012 Mar;45(3):983-91. doi: 10.1016/j.nbd.2011.12.017.

0

0

0

PUBMED

Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease.

Sarantos MR, Papanikolaou T, Ellerby LM, Hughes RE.

J Huntingtons Dis. 2012;1(2):195-210. doi: 10.3233/JHD-120033.

0

0

0

PUBMED

Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.

Anglada-Huguet M, Giralt A, Perez-Navarro E, Alberch J, Xifró X.

J Neurochem. 2012 May;121(4):639-48. doi: 10.1111/j.1471-4159.2012.07711.x.

0

0

0

PUBMED

The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?

Schipper-Krom S, Juenemann K, Reits EA.

Biochem Res Int. 2012;2012:837015. doi: 10.1155/2012/837015.

0

0

0

PUBMED

Encephalopathy, hypoglycemia, and flailing extremities: a case of bilateral chorea-ballism associated with diabetic ketoacidosis.

Guerrero WR, Okun MS, McFarland NR.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-58-235-1. doi: 10.7916/D8RX99T2.

0

0

0

PUBMED

Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.

Colle D, Hartwig JM, Soares FA, Farina M.

Brain Res Bull. 2012 Mar 10;87(4-5):397-405. doi: 10.1016/j.brainresbull.2012.01.003.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy